PlainPharmaWatch

CMS Open Payments · Program Year 2024

Harmony Biosciences LLC

Harmony Biosciences LLC reported $3,838,714.31 across General Payments, Research, and Ownership to 22,211 physicians and teaching hospitals across 23,031 transactions.

See the rankings → How this is sourced
$3.8M
All-tracks total
23,031
Transactions
22,211
Recipients
−$191.5K
General Payments vs PY2023

Harmony Biosciences LLC reported $3,838,714.31 across all CMS Open Payments tracks (General + Research + Ownership) to 22,211 physicians and teaching hospitals in Program Year 2024 - ranking #314 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,272,575.48, averaging $172.83 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer harmony-biosciences-llc Harmony Biosciences LLC

$3.8M · #314/1,925 · 0.0% industry · PY2024

  • TOT $3.8M
  • RANK #314
  • SHARE 0.0%
  • TXN 23,031
  • RCP 22,211
  • CAT 7
  • GEN $1.3M
  • ΔGEN −$191.5K
  • TOP1 4.6%
  • PY 2024

Volume peers

Nearest volume peer: Blue Earth Diagnostics Limited ($3.9M)

SmartHealth Inc$3.9MAmicus Therapeutics, Inc.$3.9MBlue Earth Diagnostics Limit…$3.9MHarmony Biosciences LLC (thi…$3.8MnView medical, Inc$3.8M
All-tracks payment totals near Harmony Biosciences LLC (CMS Open Payments PY2024)

Harmony Biosciences LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Harmony Biosciences LLC's CMS-reported General Payments decreased by $191.5K (−13.1%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: HARMONY BIOSCIENCES LLCPY2023: HARMONY BIOSCIENCES LLCPY2024: HARMONY BIOSCIENCES LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.5MPY2024$1.3M
PY2023
$1,464,116.60
PY2024
$1,272,575.48

What the Data Shows for Harmony Biosciences LLC

$3,838,714.31: that is what Harmony Biosciences LLC reported in payments to 22,211 physicians and teaching hospitals during Program Year 2024, spread across 23,031 transactions ($166.68 per transaction, $172.83 per recipient). The company sits at rank #314 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

20,588 transactions worth $493.9K make "Food and Beverage" the top general-payment category in the 7-category breakdown below, 38.8% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 7 types of general payments, Harmony Biosciences LLC's largest category was "Food and Beverage" at $493.9K - 38.8% of General Payments.

Harmony Biosciences LLC reports 7 general-payment categories - the top three are Food and Beverage (38.8%), Consulting Fee (31.7%), and Compensation for Faculty or Speaker (Medical Education) (15.5%). The remaining 4 categories make up 14.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Harmony Biosciences LLC divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$493.9K2. Consulting Fee$402.9K3. Compensation for Faculty …$197.4K4. Education$90.3K5. Travel and Lodging$59.3K6. Compensation for Services…$20.8K7. Space Rental or Facility …$8.0K
Payment Type Amount Transactions
Food and Beverage $493.9K 20,588
Consulting Fee $402.9K 273
Compensation for Faculty or Speaker (Medical Education) $197.4K 81
Education $90.3K 1,036
Travel and Lodging $59.3K 219
Compensation for Services Other Than Consulting $20.8K 12
Space Rental or Facility Fees $8.0K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $247,871.22 (19.5%) of $1,272,575.48 in this company's General Payments records across 6,256 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Harmony Biosciences LLC

The five named recipients with the highest reported General Payments from this company

Abhinav Singh$58.8KSteven Gradney$51.1KWilliam Winter$50.3KPeter Ottavio$49.4KHaramandeep Singh$38.3K
  1. 1

    Abhinav Singh

    $58,831.53 across 67 reported transactions

  2. 2

    Steven Gradney

    $51,101.03 across 61 reported transactions

  3. 3

    William Winter

    $50,279.29 across 60 reported transactions

  4. 4

    Peter Ottavio

    $49,372.41 across 71 reported transactions

  5. 5

    Haramandeep Singh

    $38,286.96 across 47 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Harmony Biosciences LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Harmony Biosciences LLC.

Jazz Pharmaceuticals Inc.

HHI 119

Microtransponder, Inc.

HHI 120

Kairos Surgical Inc

HHI 119

Antares Pharma, Inc.

HHI 119

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Harmony Biosciences LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Harmony Biosciences LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.